## Background. Little is known about the epidemiology of pain in head and neck cancer, the effects of curative treatment on this pain, and the impact that pain experience may have on patients' quality of life (QL). Method. The prevalence and severity of pain was studied in 93 patients who were fi
Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study
โ Scribed by J.R.J. De Leeuw; A. De Graeff; W.J.G. Ros; G.J. Hordijk; G.H. Blijham; J.A.M. Winnubst
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 82 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1057-9249
No coin nor oath required. For personal study only.
โฆ Synopsis
Patients with head and neck cancer have to cope not only with a life threatening diagnosis, but also with an altered facial appearance and the loss or impairment of important functions as a result of treatment. As a consequence they are prone to psychosocial problems. Social support might influence their ability to adapt to the illness and its treatment. The aim of this prospective study is to examine the influence of different aspects of social support on the depressive symptomatology in head and neck cancer patients treated with surgery and/or radiotherapy. Patients completed a questionnaire relating to available and received support, the extent of the social network, depressive symptoms, and general health complaints before and 6 months after treatment. Received support was found to be associated with more depressive symptomatology at baseline and available support led to less depressive symptomatology. The relationship between social support and depressive symptoms was especially apparent in patients with few general health complaints. Whereas the availability of support seemed to be beneficial regardless of the situation, the effect of received support was equivocal. The provision of support should be tailored to the needs of the individual patient.
๐ SIMILAR VOLUMES
Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the
A group of 154 patients with locally advanced head and neck cancer, treated with platinum-based induction chemotherapy, were followed up for 5 years and several pretreatment characteristics were analyzed for possible correlation to a complete response (CR) to chemotherapy, time to progression (TTP)